C1orf190 Activators
C1orf190 activators are a class of compounds that increase the activity of the protein encoded by the C1orf190 gene. The initial discovery process for these activators typically starts with high-throughput screening (HTS), where numerous chemical compounds are tested for their ability to modulate the activity of C1orf190. The HTS utilizes various assays that are sensitive to the protein's functional state, often relying on detectable changes in enzymatic activity that can be quantified through colorimetric or fluorescence-based readouts. Compounds that yield a positive change in these assays are marked as potential activators of C1orf190. These initial hits are then subjected to a battery of secondary assays, which are designed to refine the screening results and confirm that the compounds specifically target and activate C1orf190.
After potential C1orf190 activators are identified through the HTS and secondary assays, they undergo detailed characterization to elucidate their mode of action and interaction with the C1orf190 protein. Structural determination methods, such as X-ray crystallography or cryo-electron microscopy, are employed to gain insight into how these compounds bind to the protein at the molecular level. This information can reveal the specific areas on the protein where the activators attach and induce conformational changes leading to increased activity. Additionally, biophysical techniques like surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC) are used to measure the binding kinetics between the activators and C1orf190. These techniques provide important information on the affinity and stability of the interaction, which can inform the development of activators with optimal binding properties.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, leading to increased cAMP and cGMP levels in cells. This can enhance PKA and PKG activity, which may indirectly activate C1orf190 through phosphorylation if it is a substrate. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent PKC activator. Activation of PKC could lead to the phosphorylation and potential activation of C1orf190 if it is a substrate or part of a PKC-regulated signaling pathway. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, potentially activating calcium-dependent protein kinases that could phosphorylate and activate C1orf190 if it is involved in calcium signaling pathways. | ||||||
Spermine | 71-44-3 | sc-212953A sc-212953 sc-212953B sc-212953C | 1 g 5 g 25 g 100 g | $61.00 $196.00 $277.00 $901.00 | 1 | |
Spermine is a polyamine that can modulate ion channels and may influence signaling pathways by altering the cellular ionic environment. This could indirectly affect the function or localization of C1orf190 if it is sensitive to ionic changes. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium orthovanadate is a tyrosine phosphatase inhibitor which can lead to increased phosphorylation levels of proteins. This might enhance the activity of C1orf190 if it's regulated by tyrosine phosphorylation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor which can lead to gene demethylation and potentially upregulate genes that are epigenetically silenced. This could increase the expression of C1orf190 if its promoter is methylated. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a known broad-spectrum kinase inhibitor that could inhibit kinases that negatively regulate C1orf190, thereby potentially enhancing C1orf190 activity by relieving inhibitory phosphorylations. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a JNK activator that could potentially phosphorylate and activate transcription factors leading to upregulation of genes including C1orf190, if it is regulated by JNK signaling pathways. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to increased intracellular Ca2+ levels, which could activate calcium-dependent signaling pathways, potentially resulting in the activation of C1orf190 if it is part of these pathways. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid is a regulator of gene expression that acts through retinoic acid receptors. It can modulate the expression of a wide range of genes, potentially including C1orf190 if it is responsive to retinoic acid signaling. | ||||||